A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Inclusion Criteria: * Good activity level * Life expectancy of ≥ 6 months * Solid tumor malignancy for which paclitaxel and carboplatin are appropriate Exclusion Criteria: * Major surgery within 4 weeks * Any concurrent cancer * History of autoimmune diseases * Symptomatic bowel obstruction * Continued use of steroids * Symptomatic brain metastases * Current nerve damage in fingers/toes * Positive for HIV, hepatitis B/C * White blood cells \< 3,000 * Hemoglobin \< 9 * Platelets \< 100,000 * ALT/AST and/or alkaline phosphatase \>= 2.5 x ULN * Creatine \> 1.5 * Prior BMS-663513